|
A team from Lawson Health Research Institute are being funded by the Government of Ontario's COVID-19 Rapid Research Fund to study whether inhaled sedatives can replace those that are delivered intravenously in COVID-19 patients requiring ventilation. The multi-center clinical trial aims to address a global shortage of intravenous (IV) sedatives while improving patient outcomes.
|